Insulet is a major player when it comes to insulin pump therapy for diabetes. Billerica, Mass.–based Insulet touts its Omnipod system as an easy-to-use tubeless insulin pump. It provides up to three days of non-stop insulin delivery, and users don’t need to handle a needle. Investor demand for the company’s stock is so strong that Insulet announced in November that it was up-sizing a private placement to $350 million in convertible senior notes due in 2024, up from a previous $300 million.
DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.
Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry.
Was going to read this article but refuse to go through multiple clicks to see a list. Can you just give the list?
There’s a link on the opening slide where you can download a full spreadsheet of 100 companies and their stock performance. Hope that helps.